AMPHASTAR PHARMACEUTICALS IN's ticker is AMPH and the CUSIP is 03209R103. A total of 108 filers reported holding AMPHASTAR PHARMACEUTICALS IN in Q2 2017. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $248,000 | -33.5% | 11,758 | -35.5% | 0.00% | -55.6% |
| Q1 2019 | $373,000 | +67.3% | 18,231 | +57.2% | 0.01% | +125.0% |
| Q3 2018 | $223,000 | +13.2% | 11,600 | +13.0% | 0.00% | +33.3% |
| Q4 2017 | $197,000 | -55.3% | 10,261 | -58.4% | 0.00% | -40.0% |
| Q2 2017 | $441,000 | -48.2% | 24,680 | -58.0% | 0.01% | -50.0% |
| Q1 2017 | $852,000 | +50.0% | 58,746 | +90.4% | 0.01% | +66.7% |
| Q4 2016 | $568,000 | – | 30,862 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| LAM GROUP, INC. | 128,000 | $5,886,720 | 5.78% |
| Beacon Harbor Wealth Advisors, Inc. | 103,095 | $4,741 | 1.58% |
| Capital Impact Advisors, LLC | 15,304 | $703,831 | 1.18% |
| Quantedge Capital Pte Ltd | 36,389 | $1,673,530 | 0.91% |
| Mesirow Institutional Investment Management, Inc. | 183,805 | $8,453,192 | 0.86% |
| Monashee Investment Management LLC | 39,461 | $1,814,811 | 0.76% |
| OBERWEIS ASSET MANAGEMENT INC/ | 152,500 | $7,013,475 | 0.74% |
| Granite Investment Partners, LLC | 330,911 | $15,218,597 | 0.64% |
| Portolan Capital Management | 132,850 | $6,109,772 | 0.57% |
| SHAKER INVESTMENTS LLC/OH | 20,795 | $956,362 | 0.53% |